SOD1 and diabetes mellitus: Several studies have reported that Nrf2 antioxidative dysfunction occurs in diabetes and activation of Nrf2 clearly upregulates HO-1, SOD, and GPx expressions to reduce diabetic cardiomyopathy and myocardial I/R injury [12–15].